Spring til hovednavigation Spring til søgning Spring til hovedindhold

EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE (R2) IN PREVIOUSLY UNTREATED (1L) FOLLICULAR LYMPHOMA (FL) AND EPCORITAMAB MAINTENANCE THERAPY IN FL: NOVEL RESULTS FROM EPCORE NHL‑2 ARMS 6 AND 7

  • Lorenzo Falchi*
  • , Joost S.P. Vermaat
  • , Gerardo Musuraca
  • , Marcel Nijland
  • , Jacob Haaber Christensen
  • , Fritz Offner
  • , Lori A. Leslie
  • , Joshua Brody
  • , Daniela Hoehn
  • , Jennifer Marek
  • , Liwei Wang
  • , Jian Mei
  • , David Belada
  • , Pau Abrisqueta
  • *Kontaktforfatter
  • Memorial Sloan-Kettering Cancer Center
  • Leiden University Medical Center
  • University Medical Center Groningen
  • Ghent University Hospital
  • Hackensack University Medical Center
  • Icahn School of Medicine at Mount Sinai
  • Genmab US, Inc
  • AbbVie, North Chicago,
  • Charles University
  • University Hospital Hradec Králové
  • Vall d'Hebron University Hospital

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskningpeer review

OriginalsprogEngelsk
Publikationsdatojun. 2024
StatusUdgivet - jun. 2024
BegivenhedEHA 2024 Hybrid Conference - Madrid, Spanien
Varighed: 13. jun. 202416. jun. 2024

Konference

KonferenceEHA 2024 Hybrid Conference
Land/OmrådeSpanien
ByMadrid
Periode13/06/202416/06/2024

Citationsformater